RESISTANCE TO PLATINUM COMPOUNDS - MECHANISMS AND BEYOND

[1] AAMDAL S, 1986, P AM ASSOC CANC RES, P292

[2] ANDREWS PA, 1985, CANCER RES, V45, P6250

[3] ANDREWS PA, 1988, CANCER RES, V48, P68

[4] BOHM S, 1987, 5TH INT P S PLAT OTH, P243

[5] Borch RF, 1987, METABOLISM ACTION AN, P163

[6] CLINICAL-TRIALS OF WR-2721 PRIOR TO ALKYLATING AGENT CHEMOTHERAPY AND RADIOTHERAPY [J]. PHARMACOLOGY & THERAPEUTICS, 1988, 39 (1-3) : 3 - 7

[7] GLOVER D, COMMUNICATION

[8] GOLDIE JH, 1984, CANCER RES, V44, P3643

[9] HIGH-DOSE CARBOPLATIN IN THE TREATMENT OF LUNG-CANCER AND MESOTHELIOMA - A PHASE-I DOSE ESCALATION STUDY [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (09): : 1391 - 1397

[10] GROSS RB, 1986, CHEMIOTERAPIA, V5, P37

[1] AAMDAL S, 1986, P AM ASSOC CANC RES, P292

[2] ANDREWS PA, 1985, CANCER RES, V45, P6250

[3] ANDREWS PA, 1988, CANCER RES, V48, P68

[4] BOHM S, 1987, 5TH INT P S PLAT OTH, P243

[5] Borch RF, 1987, METABOLISM ACTION AN, P163

[6] CLINICAL-TRIALS OF WR-2721 PRIOR TO ALKYLATING AGENT CHEMOTHERAPY AND RADIOTHERAPY [J]. PHARMACOLOGY & THERAPEUTICS, 1988, 39 (1-3) : 3 - 7

[7] GLOVER D, COMMUNICATION

[8] GOLDIE JH, 1984, CANCER RES, V44, P3643

[9] HIGH-DOSE CARBOPLATIN IN THE TREATMENT OF LUNG-CANCER AND MESOTHELIOMA - A PHASE-I DOSE ESCALATION STUDY [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (09): : 1391 - 1397

[10] GROSS RB, 1986, CHEMIOTERAPIA, V5, P37